Skip to main content
SpringerLink
Log in

Uveal Melanoma: Histopathologic Features

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

  • 592 Accesses

Abstract

Uveal melanomas develop from melanocytes that reside within the stroma of the choroid, ciliary body, and iris. No basement membrane is breached when the tumor develops.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Folberg R. Tumor progression in ocular melanomas. J Investig Dermatol. 1993;100(3):326S–31S.

    Article  CAS  PubMed  Google Scholar 

  2. Reese AB, Howard GM. Flat uveal melanomas. Am J Ophthalmol. 1967;64(6):1021–8.

    Google Scholar 

  3. Stadigh A, Puska P, Vesti E, et al. Ring melanoma of the anterior chamber angle as a mimicker of pigmentary glaucoma. Surv Ophthalmol. 2017;62(5):670–6.

    Article  PubMed  Google Scholar 

  4. Demirci H, Shields CL, Shields JA, et al. Ring melanoma of the ciliary body. Retina. 2002;22(6):698–706.

    Article  PubMed  Google Scholar 

  5. Aziz HA, Modi YS, Plesec TP, et al. Amelanotic irido-ciliary ring melanoma: a clinicopathological correlation. Ocul Oncol Pathol. 2016;2(3):153–5.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kivelä T, Summanen P. Retinoinvasive malignant melanoma of the uvea. Br J Ophthalmol. 1997;81(8):691–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gorham JP, Szalai E, Wells JR, et al. Retinoinvasive uveal melanoma: report of 2 cases and review of the literature. Ocul Oncol Pathol. 2017;3(4):292–5.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma. Ophthalmology. 2008;115(10):1778–85.

    Article  PubMed  Google Scholar 

  9. van Beek JGM, Koopmans AE, Vaarwater J, et al. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma. Invest Opthalmol Vis Sci. 2014;55(3):1284.

    Google Scholar 

  10. Muen WJ, Damato BE. Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy. Eye. 2006;21(2):307–8.

    Article  PubMed  Google Scholar 

  11. Burris CKH, Papastefanou VP, Thaung C, et al. Detection of extrascleral extension in uveal melanoma with histopathological correlation. Orbit. 2018;37(4):287–92.

    Article  PubMed  Google Scholar 

  12. Singh AD, Eagle RC Jr, Shields CL, et al. Clinicopathologic reports, case reports, and small case series: enucleation following transpupillary thermotherapy of choroidal melanoma: clinicopathologic correlations. Arch Ophthalmol. 2003;121(3):397–400.

    Article  PubMed  Google Scholar 

  13. Ayres B, Elner V, Demirci H. Massive extraocular extension of choroidal melanoma after brachytherapy. Ophthalmology. 2017;124(10):1503.

    Article  PubMed  Google Scholar 

  14. Spencer WH. Optic nerve extension of intraocular neoplasms. Am J Ophthalmol. 1975;80(3):465–71.

    Article  CAS  PubMed  Google Scholar 

  15. Kivelä T, Eskelin S, Mäkitie T, et al. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci. 2001;42(9):2085–93.

    Google Scholar 

  16. McMenamin PG, Lee WR. Ultrastructural pathology of melanomalytic glaucoma. Br J Ophthalmol. 1986;70(12):895–906.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Callender GR. Malignant melanocytic tumors of the eye. A study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol. 1931;36:131–40.

    Google Scholar 

  18. McLean IW, Zimmerman LE, Evans RM. Reappraisal of Callender’s spindle a type of malignant melanoma of choroid and ciliary body. Am J Ophthalmol. 1978;86(4):557–64.

    Article  CAS  PubMed  Google Scholar 

  19. McLean IW, Foster WD, Zimmerman LE, et al. Modifications of Callender’s classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983;96(4):502–9.

    Article  CAS  PubMed  Google Scholar 

  20. Shah AA, Bourne TD, Murali R. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Pathology. 2013;45(7):651–6.

    Article  CAS  PubMed  Google Scholar 

  21. Moshari A, McLean IW. Uveal melanoma: mean of the longest nucleoli measured on silver-stained sections. Invest Ophthalmol Vis Sci. 2001;42(6):1160–3.

    CAS  PubMed  Google Scholar 

  22. McLean IW, Keefe KS, Burnier MN. Uveal melanoma. Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size. Ophthalmology. 1997;104(5):777–80.

    Article  CAS  PubMed  Google Scholar 

  23. Seregard S, Spångberg B, Juul C, et al. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology. 1998;105(3):485–91.

    Article  CAS  PubMed  Google Scholar 

  24. Al-Jamal RT, Mäkitie T, Kivelä T. Nucleolar diameter and microvascular factors as independent predictors of mortality from malignant melanoma of the choroid and ciliary body. Invest Opthalmol Vis Sci. 2381;44(6):2003.

    Google Scholar 

  25. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100(9):1389–98.

    Article  CAS  PubMed  Google Scholar 

  26. Folberg R, Pe’er J, Gruman LM, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol. 1992;23(11):1298–305.

    Article  CAS  PubMed  Google Scholar 

  27. Toivonen P, Mäkitie T, Kujala E, et al. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Opthalmol Vis Sci. 2004;45(1):1.

    Article  Google Scholar 

  28. Rummelt V, Folberg R, Rummelt C, et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. Ophthalmology. 1994;101(4):718–27.

    Article  CAS  PubMed  Google Scholar 

  29. Mäkitie T, Summanen P, Tarkkanen A, et al. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. JNCI J Natl Cancer Inst. 1999;91(4):359–67.

    Article  CAS  PubMed  Google Scholar 

  30. Biscotti CV, Singh AD. Uveal melanoma: diagnostic features. Monogr Clin Cytol. 2012;21:44–54.

    Article  PubMed  Google Scholar 

  31. Medina CA, Biscotti CV, Singh N, et al. Diagnostic cytologic features of uveal melanoma. Ophthalmology. 2015;122(8):1580–4.

    Article  PubMed  Google Scholar 

  32. Shields CL, Shields JA, Gross NE, et al. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104(8):1265–76.

    Article  CAS  PubMed  Google Scholar 

  33. Bellerive C, Biscotti CV, Singh AD. Fine needle aspiration biopsy for suspected uveal metastases. Can J Ophthalmol. 2019. [epub ahead of print].

    Google Scholar 

  34. Faulkner-Jones BE, Foster WJ, Harbour JW, et al. Fine needle aspiration biopsy with adjunct immunohistochemistry in intraocular tumor management. Acta Cytol. 2005;49(3):297–308.

    Article  PubMed  Google Scholar 

  35. Kivelä T. Immunohistochemical staining followed by bleaching of melanin: a practical method for ophthalmic pathology. Br J Biomed Sci. 1995;52(4):325–6.

    Google Scholar 

  36. Koopmans AE, Verdijk RM, Brouwer RWW, et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol. 2014;27(10):1321–30.

    Article  CAS  PubMed  Google Scholar 

  37. van de Nes JA, Nelles J, Kreis S, et al. Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma. Am J Surg Pathol. 2016;40(6):796–805.

    Article  PubMed  Google Scholar 

  38. Herwig-Carl MC, Sharma A, Moulin A, et al. BAP1 immunostaining in uveal melanoma: potentials and pitfalls. Ocul Oncol Pathol. 2018;4(5):297.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Foss AJ, Alexander RA, Jefferies LW, et al. Microvessel count predicts survival in uveal melanoma. Cancer Res. 1996;56(13):2900–3.

    CAS  PubMed  Google Scholar 

  40. Mäkitie T, Summanen P, Tarkkanen A, et al. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999;40(11):2471–80.

    Google Scholar 

  41. Chen X, Maniotis AJ, Majumdar D, et al. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci. 2002;43(8):2533–9.

    PubMed  Google Scholar 

  42. Mäkitie T, Summanen P, Tarkkanen A, Kivelä T. Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42(7):1414–21.

    Google Scholar 

  43. De Cruz POL, Specht CS, McLean IW. Lymphocytic infiltration in uveal malignant melanoma. Cancer. 1990;65(1):112–5.

    Article  PubMed  Google Scholar 

  44. Bronkhorst IH, Vu TH, Jordanova ES, et al. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Invest Ophthalmol Vis Sci. 2012;53(9):5370–8.

    Article  CAS  PubMed  Google Scholar 

  45. Staibano S, Mascolo M, Tranfa F, et al. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? Int J Immunopathol Pharmacol. 2006;19(1):171–9.

    Article  CAS  PubMed  Google Scholar 

  46. Al-Jamal RT, Kivelä T. KI-67 Immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors. Curr Eye Res. 2006;31(1):57–67.

    Article  CAS  PubMed  Google Scholar 

  47. Blom DJ, Luyten GP, Mooy C, et al. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma. Invest Ophthalmol Vis Sci. 1997;38(9):1865–72.

    CAS  PubMed  Google Scholar 

  48. Fuchs U, Kivelä T, Summanen P, et al. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma. Am J Pathol. 1992;141(1):169–81.

    Google Scholar 

  49. Hendrix MJ, Seftor EA, Seftor RE, et al. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. Lab Investig. 1998;78(2):153–63.

    CAS  PubMed  Google Scholar 

  50. Fuchs U, Kivelä T, Tarkkanen A, et al. Histopathology of enucleated intraocular melanomas irradiated with cobalt and ruthenium plaques. Acta Ophthalmol. 2009;66(3):255–66.

    Article  Google Scholar 

  51. Saornil MA. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992;110(8):1112.

    Article  CAS  PubMed  Google Scholar 

  52. Echegaray JJ, Plesec TT, Bellerive C, et al. Histopathologic patterns of recurrent choroidal melanoma following I-125 plaque brachytherapy. Ocul Oncol Pathol. 2019. [epub ahead of print].

    Google Scholar 

  53. Harbour JW, Char DH, Kroll S, et al. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology. 1997;104(11):1785–92.

    Article  CAS  PubMed  Google Scholar 

  54. Griewank KG, van de Nes J, Schilling B, et al. Genetic and clinico-pathologic analysis of metastatic uveal melanoma. Mod Pathol. 2013;27:175.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ocular Oncology and Ophthalmic Pathology, Helsinki University Hospital, Helsinki, Finland

    Tero T. Kivelä

  2. Department of Ophthalmology, University of Helsinki, Helsinki, Finland

    Tero T. Kivelä

Authors
  1. Tero T. Kivelä
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tero T. Kivelä .

Editor information

Editors and Affiliations

  1. University of Oxford, Oxford, UK

    Bertil E. Damato

  2. Cole Eye Institute Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kivelä, T.T. (2019). Uveal Melanoma: Histopathologic Features. In: Damato, B., Singh, A. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-17879-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17879-6_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17878-9

  • Online ISBN: 978-3-030-17879-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation